These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 21080246

  • 1. Management of refractory ascites and hepatorenal syndrome.
    Sussman AN, Boyer TD.
    Curr Gastroenterol Rep; 2011 Feb; 13(1):17-25. PubMed ID: 21080246
    [Abstract] [Full Text] [Related]

  • 2. Management of ascites and hepatorenal syndrome.
    Piano S, Tonon M, Angeli P.
    Hepatol Int; 2018 Feb; 12(Suppl 1):122-134. PubMed ID: 28836115
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ascites and Hepatorenal Syndrome.
    Adebayo D, Neong SF, Wong F.
    Clin Liver Dis; 2019 Nov; 23(4):659-682. PubMed ID: 31563217
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Influence of circulatory dysfunction on the treatment of ascites and hepatorenal syndrome: vasoconstrictor and diuretic drug treatment].
    Torre A, Terra C, Guevara M, Ginès P.
    Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():8-14. PubMed ID: 15195529
    [No Abstract] [Full Text] [Related]

  • 8. Current management and novel therapeutic strategies for refractory ascites and hepatorenal syndrome.
    Suzuki H, Stanley AJ.
    QJM; 2001 Jun; 94(6):293-300. PubMed ID: 11391027
    [Abstract] [Full Text] [Related]

  • 9. [Ascites, hepatorenal syndrome and spontaneous bacterial peritonitis in patients with portal hypertension].
    Kim YS.
    Korean J Gastroenterol; 2010 Sep; 56(3):168-85. PubMed ID: 20847607
    [Abstract] [Full Text] [Related]

  • 10. Practical recommendations for the treatment of ascites and its complications.
    Bataller R, Ginès P, Arroyo V.
    Drugs; 1997 Oct; 54(4):571-80. PubMed ID: 9339961
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Hepatorenal syndrome: diagnosis, treatment and prevention].
    Egerod Israelsen M, Gluud LL, Bendtsen F, Møller S, Krag AA.
    Ugeskr Laeger; 2013 May 27; 175(22):1562-6. PubMed ID: 23721840
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Minimizing ascites. Complication of cirrhosis signals clinical deterioration.
    Garcia N, Sanyal AJ.
    Postgrad Med; 2001 Feb 27; 109(2):91-6, 101-3. PubMed ID: 11272697
    [Abstract] [Full Text] [Related]

  • 18. Cirrhosis and chronic liver failure: part II. Complications and treatment.
    Heidelbaugh JJ, Sherbondy M.
    Am Fam Physician; 2006 Sep 01; 74(5):767-76. PubMed ID: 16970020
    [Abstract] [Full Text] [Related]

  • 19. Treatment of the hepatorenal syndrome and hyponatremia in cirrhosis - part II.
    Møller S, Aagaard NK, Schmidt L, Grønbaek H, Hansen JB, Bendtsen F.
    Dan Med J; 2012 Jan 01; 59(1):C4372. PubMed ID: 22239848
    [Abstract] [Full Text] [Related]

  • 20. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G, Ferro C, Sumberaz A, Messa P, Morelli N, Guadagni B, Ardizzone G, Valente U.
    Hepatogastroenterology; 2003 Jan 01; 50(54):1753-5. PubMed ID: 14696397
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.